About
Scott Forrest, Ph.D. is a biotech executive focused on finance, business development, and company creation. As of 2026, he serves as Chief Financial Officer at Navigator Medicines; previously he held senior roles at Shoreline Biosciences, Autobahn Therapeutics, Inception Therapeutics, BlackThorn Therapeutics, and The Scripps Research Institute. Public sources describe him as an operator and advisor who has helped launch multiple biotech companies and manage major corporate alliances, but not as a documented investor.
Areas of interest
biotechdrug discoverycell therapyimmunologyautoimmune diseaseCNS disorderscorporate developmentportfolio planningfinancial strategytechnology transfercompany creation